What is the primary pathophysiological feature of chronic bronchitis?
Excessive mucus production and bronchial inflammation
Impaired gas exchange due to ventilation-perfusion mismatch
Alveolar destruction and airspace enlargement
Constriction of airway smooth muscles and bronchoconstriction
The Correct Answer is A
A. Chronic bronchitis is clinically defined by a chronic productive cough resulting from hypersecretion of mucus by goblet cells and enlarged submucosal glands. Chronic exposure to irritants, such as cigarette smoke, triggers a persistent inflammatory response in the larger and smaller airways. This leads to the characteristic thickening of the bronchial walls and the significant narrowing of the airway lumens.
B. While impaired gas exchange and V/Q mismatching occur as a consequence of the disease, they are secondary effects rather than the "primary" defining feature. The primary issue is the physical obstruction created by mucus and edema, which then leads to these subsequent physiological disturbances. The underlying pathology must be addressed to understand the cause of the resulting ventilation-perfusion abnormalities.
C. Alveolar destruction and permanent enlargement of the airspaces distal to the terminal bronchioles are the primary features of emphysema, not chronic bronchitis. Although both are types of COPD, emphysema focuses on the loss of elastic recoil and surface area for gas exchange in the alveoli. Chronic bronchitis is focused specifically on the inflammatory processes within the conducting bronchial tubes.
D. Constriction of airway smooth muscles and acute bronchoconstriction are the hallmark pathophysiological features of asthma rather than chronic bronchitis. While patients with bronchitis may have some airway reactivity, their primary obstruction is due to structural changes and mucus plugging. Asthma is distinguished by its reversible nature and the specific involvement of hyperreactive smooth muscle contraction.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. Restoring fluid and electrolyte balance is a fundamental goal in managing renal failure to prevent cardiovascular collapse and neurological irritability. However, these interventions do not specifically target the accumulation of uremic toxins within the dermal layers. While necessary for systemic stability, it does not directly alleviate the refractory itching associated with uremia.
B. Controlling potassium levels is a life-saving measure to prevent lethal cardiac arrhythmias in patients with declining renal function. Although hyperkalemia is a critical component of uremic syndrome, it does not physiologically contribute to the sensation of pruritus. The skin changes are primarily driven by calcium-phosphate imbalances and nitrogenous waste accumulation rather than potassium.
C. A restricted protein diet helps reduce the production of nitrogenous waste products like urea, which may slightly mitigate systemic uremic symptoms. However, once a patient exhibits severe integumentary changes like uremic frost or intense pruritus, dietary modification alone is insufficient. This conservative measure is typically used in earlier stages of chronic kidney disease.
D. Dialysis is the most effective treatment for uremic pruritus because it mechanically filters out the middle molecules and uremic toxins that trigger nerve endings in the skin. By removing excess urea and creatinine from the blood, dialysis reduces the systemic "toxic" load that causes integumentary irritation. It is the definitive intervention for stage 5 renal symptoms.
Correct Answer is A
Explanation
A. Stage A heart failure identifies individuals at high risk for developing heart failure but who currently possess no structural heart disease or symptoms. The primary clinical objective is the aggressive management of underlying conditions such as hypertension, lipid disorders, and diabetes mellitus. Implementing strict lifestyle modifications and pharmacological risk control prevents the progression toward cardiac remodeling and symptomatic dysfunction.
B. Diuretics are pharmacological agents utilized primarily in Stage C heart failure to manage clinical manifestations of fluid overload and pulmonary congestion. Because Stage A patients do not exhibit structural abnormalities or subjective symptoms of volume expansion, diuretic therapy is physiologically inappropriate. Administering these medications without clinical indication can lead to unnecessary adverse effects like electrolyte depletion and hypovolemia.
C. Coronary angiography is an invasive diagnostic procedure indicated for patients with suspected obstructive coronary artery disease or those requiring mechanical revascularization. It is not a standard or appropriate intervention for Stage A heart failure management in the absence of acute ischemic symptoms. Management at this stage remains non-invasive, focusing on systemic physiological optimization rather than invasive cardiac catheterization or surgical intervention.
D. Beta-blocker therapy is a cornerstone for patients in Stage B or C who have a reduced left ventricular ejection fraction. While certain Stage A patients might take beta-blockers for comorbid hypertension, they are not the definitive intervention for the Stage A classification itself. The priority remains multifaceted risk factor modification to protect the myocardium from the initial stages of structural damage and maladaptive hypertrophy.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.